Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of TBAJ-876 in Healthy Adults
NCT04493671Phase 1Completed
- Sponsor
- TB Alliance
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sorfequiline in Tuberculosis (TB) (16 arms), sponsored by TB Alliance. Primary endpoint: Number of Participants with Treatment-Related Adverse Events. Started Jun 2020; status: completed.
02
Drugs
sorfequiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04493671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04493671.